- Home
- RBOT
as 06-20-2025 3:40pm EST
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 46.7M | IPO Year: | N/A |
| Target Price: | $9.25 | AVG Volume (30 days): | 9.8K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.27 - $19.00 | Next Earning Date: | 08-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vicarious Surgical Inc. News
RBOT Breaking Stock News: Dive into RBOT Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Here's Why We're A Bit Worried About Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
GlobeNewswire
24 days ago
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
GuruFocus.com
a month ago
Vicarious Surgical Inc (RBOT) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...
Business Wire
a month ago
Vicarious Surgical Reports First Quarter 2025 Financial Results
Business Wire
a month ago
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center
Business Wire
2 months ago
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025
Business Wire
2 months ago
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE
Business Wire
3 months ago
Vicarious Surgical Announces President Transition to Board Member Role
Compare RBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RBOT Vicarious Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.